A stop-gain variant in BTNL9 is associated with atherogenic lipid profiles.
Meta-analysis · HGG Adv · 2023. Source record refreshed; an explanation has not been reviewed.
About this paper
This page identifies the publication and its source. A checked explanation of its findings is not yet available.
Reading this record
Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.
Publication details
A stop-gain variant in BTNL9 is associated with atherogenic lipid profiles.
Carlson JC, Krishnan M, Rosenthal SL et al.
HGG Adv · 2023
- PubMed ID
- 36340932
- Record checked
A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.
Keep your place in the research.
Save this source or mark it as read.